AprilBio에이프릴바이오

AprilBio397030· Biotech & PharmaInitiation

AprilBio: Shares Down 55.7% Over a Year as Revenue Fades and Losses Persist

AprilBio's shares closed at ₩12,750 on 2026-10-23, down 29.6% in one month and 55.7% over one year, near the 52-week low of ₩11,810. Filed numbers show revenue of just ₩725M over the trailing twelve months to H1 2026 and an operating loss of ₩9.6B, after a profitable 2024.

Oct 24, 20260 views